Studies Call Attention To Ethics Of Industry Support

Sidebar: Fourteen Journals Surveyed on Financial Interest of Authors For More Information On Academic-Industrial Collaborations Two recent studies have renewed attention on the perennial controversy over industry support of academic research. Some observers maintain that conflict-of-interest issues inherent in academic-industrial collaborations compromise scientific integrity and contribute to the public's mistrust of science, while others argue that such relationships benefit society and are a

Written byKaren Young Kreeger
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Sidebar: Fourteen Journals Surveyed on Financial Interest of Authors
For More Information On Academic-Industrial Collaborations


ENSURING HONOR:Lenoard Minsky contends that only compulsory disclosure of financial interests on research papers guarantees integrity.
One analysis, led by Sheldon Krimsky, a professor of urban and environmental policy at Tufts University, found that 34 percent of the articles examined had a first or last author from academia with a financial interest in the described research (S. Krimsky et al., Science and Engineering Ethics, 2:396-410, 1996). Virtually none of these papers made note of that relationship.

The other study, led by David Blumenthal, chief of the health policy research and development unit at Massachusetts General Hospital, found that faculty members receiving corporate funds had more peer-reviewed articles published-up to a point (D. Blumenthal et al., New England Journal of Medicine, 335:1734-9, 1996). His team also found that academics who received more than two-thirds of their ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies